Scott McKeown Quoted by Law360 on Allergan Decision
2 min read
Scott McKeown was quoted by Law360 in an article titled “Federal Circuit Quells Fears Over Double-Patenting Overreach.” This article covers how the recent Federal Circuit ruling in Allergan v. MSN Labs alleviates concerns among attorneys about potential vulnerabilities related to extended expiration dates due to regulatory delays. Scott discusses that while the decision does offer some clarity, in instances where a first patent is narrower than the second, there may be some wrinkles to the decision. Read more (subscription required).
Related content:
- Allergan ‘First’ Exception to Cellect ODP Scenarios
- Rob Sahr Quoted by IPWatchdog on Allergan Decision
- In re Cellect: What In-House Counsel Needs to be Doing Right Now
- Rob Sahr Quoted by IPWatchdog on In re Cellect
- Wolf Greenfield Webinar: Avoiding the “Cellect-ion” of your Patent Portfolio: What You Need to Know Now About PTA & PTE in the New Double Patenting Environment